April 25, 2022
April 25, 2022 – The U.S. FDA has approved Epsolay® (benzoyl peroxide, cream, 5%), from Sol-Gel Technologies, to treat inflammatory lesions of rosacea in adults.
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
GlobalReach Health
April 25, 2022
April 25, 2022 – Veklury® (remdesivir) is now indicated to treat patients as young as 28 days and weighing at least 3kg (7 pounds) who have positive results of direct SARS-CoV-2
April 22, 2022
April 22, 2022 – Pfizer has recalled five lots of Accupril® (quinapril HCl) tablets due to the presence of a
nitrosamine identified as above the established acceptable daily intake
April 21, 2022
April 21, 2022 – Zerbaxa® (ceftolozane/tazobactam) has received an expanded indication to treat complicated intra-abdominal infections and complicated urinary tract infections
April 14, 2022
April 4, 2022 – Several years following FDA approval, Ibsrela® (tenapanor) oral tablets are now available to treat irritable bowel syndrome with constipation (IBS-C) in adults
April 14, 2022
March 29, 2022 – Teva Pharmaceuticals has recalled lot 31329657B of IDArubicin Hydrochloride Injection USP 5mg/5mL vials. An internal inspection found one vial contained silica
April 14, 2022
April 14, 2022 – The U.S. FDA has approved Imcivree® (setmelanotide) for treatment of obesity and control of hunger in patients who are at least six years old and have Bardet-Biedl
April 13, 2022
April 13, 2022 – Amneal has received FDA approval for Alymsys® (bevacizumab-maly) intravenous injection, a biosimilar to Genentech’s Avastin®